DataSheet1_Recent Advances in Pharmacological Intervention of Osteoarthritis: A Biological Aspect.PDF (182.69 kB)
Download file

DataSheet1_Recent Advances in Pharmacological Intervention of Osteoarthritis: A Biological Aspect.PDF

Download (182.69 kB)
dataset
posted on 23.11.2021, 04:55 by Jinxia Deng, Zhixian Zong, Zhanpeng Su, Haicong Chen, Jianping Huang, Yanru Niu, Huan Zhong, Bo Wei

Osteoarthritis (OA) is a degenerative joint disease in the musculoskeletal system with a relatively high incidence and disability rate in the elderly. It is characterized by the degradation of articular cartilage, inflammation of the synovial membrane, and abnormal structure in the periarticular and subchondral bones. Although progress has been made in uncovering the molecular mechanism, the etiology of OA is still complicated and unclear. Nevertheless, there is no treatment method that can effectively prevent or reverse the deterioration of cartilage and bone structure. In recent years, in the field of pharmacology, research focus has shifted to disease prevention and early treatment rather than disease modification in OA. Biologic agents become more and more attractive as their direct or indirect intervention effects on the initiation or development of OA. In this review, we will discuss a wide spectrum of biologic agents ranging from DNA, noncoding RNA, exosome, platelet-rich plasma (PRP), to protein. We searched for key words such as OA, DNA, gene, RNA, exosome, PRP, protein, and so on. From the pharmacological aspect, stem cell therapy is a very special technique, which is not included in this review. The literatures ranging from January 2016 to August 2021 were included and summarized. In this review, we aim to help readers have a complete and precise understanding of the current pharmacological research progress in the intervention of OA from the biological aspect and provide an indication for the future translational studies.

History

References